Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* CDAI \> 220 und \< 450~* Biologika naiv~* CD seit \> 6 Monaten~Exclusion criteria:~* other TNF-Blocker~* Steroids \> 40 mg~* Malignoma in der Anamnesis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).